SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001019056-21-000350
Filing Date
2021-06-02
Accepted
2021-06-02 19:30:54
Documents
1
Period of Report
2021-05-24

Document Format Files

Seq Description Document Type Size
1 kwon.html 3  
1 kwon.xml 3 1597
  Complete submission text file 0001019056-21-000350.txt   2943
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Issuer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address APTEVO THERAPEUTICS INC. 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121
Business Address
Kwon SoYoung (Reporting) CIK: 0001864406 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37746 | Film No.: 21990824